|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 75.70 SEK | +0.93% |
|
+4.13% | -13.93% |
| 02-03 | Berenberg Lowers Target Price for Hexpol to 74 Kronor (95), Reiterates Hold - BN | FW |
| 02-02 | SB1 Markets Lowers Target Price for Hexpol to 92 Kronor (102), Reiterates Buy | FW |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 7.52 | 12.73 | 9.85 | 9.95 | 8.6 | |||||
Return on Total Capital | 9.51 | 16.3 | 12.76 | 12.93 | 11.11 | |||||
Return On Equity % | 14.92 | 22.69 | 19.54 | 17.81 | 14.55 | |||||
Return on Common Equity | 14.92 | 22.69 | 19.54 | 17.81 | 14.55 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 21.96 | 21.89 | 19.53 | 22.04 | 21.46 | |||||
SG&A Margin | 6.73 | 4.36 | 4.3 | 4.97 | 5.03 | |||||
EBITDA Margin % | 17.24 | 22.91 | 16.51 | 18.73 | 18.38 | |||||
EBITA Margin % | 15.14 | 21.49 | 15.15 | 17.2 | 16.63 | |||||
EBIT Margin % | 14.56 | 21.02 | 14.71 | 16.62 | 15.96 | |||||
Income From Continuing Operations Margin % | 10.5 | 14.73 | 11.16 | 11.45 | 10.86 | |||||
Net Income Margin % | 10.5 | 14.73 | 11.16 | 11.45 | 10.86 | |||||
Net Avail. For Common Margin % | 10.5 | 14.73 | 11.16 | 11.45 | 10.86 | |||||
Normalized Net Income Margin | 8.73 | 12.97 | 9.06 | 9.74 | 9.45 | |||||
Levered Free Cash Flow Margin | 11.43 | 10.3 | 4.55 | 11.21 | 9.25 | |||||
Unlevered Free Cash Flow Margin | 11.69 | 10.47 | 4.83 | 11.87 | 9.95 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.83 | 0.97 | 1.07 | 0.96 | 0.86 | |||||
Fixed Assets Turnover | 5.49 | 6.82 | 7.86 | 6.55 | 5.62 | |||||
Receivables Turnover (Average Receivables) | 7.2 | 7.72 | 8.12 | 7.8 | 7.79 | |||||
Inventory Turnover (Average Inventory) | 8.43 | 8.83 | 8.54 | 7.56 | 7.44 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.63 | 1.08 | 1.12 | 1.08 | 0.93 | |||||
Quick Ratio | 1.19 | 0.74 | 0.74 | 0.71 | 0.61 | |||||
Operating Cash Flow to Current Liabilities | 0.91 | 0.46 | 0.39 | 0.6 | 0.37 | |||||
Days Sales Outstanding (Average Receivables) | 50.81 | 47.26 | 44.95 | 46.8 | 47 | |||||
Days Outstanding Inventory (Average Inventory) | 43.41 | 41.36 | 42.75 | 48.27 | 49.2 | |||||
Average Days Payable Outstanding | 67.4 | 58.68 | 54.34 | 63.44 | 59.86 | |||||
Cash Conversion Cycle (Average Days) | 26.82 | 29.94 | 33.37 | 31.63 | 36.34 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 30.61 | 19.07 | 31.91 | 18.41 | 21.78 | |||||
Total Debt / Total Capital | 23.44 | 16.02 | 24.19 | 15.54 | 17.89 | |||||
LT Debt/Equity | 29.55 | 2.58 | 13.23 | 4.7 | 2.2 | |||||
Long-Term Debt / Total Capital | 22.63 | 2.17 | 10.03 | 3.97 | 1.8 | |||||
Total Liabilities / Total Assets | 39.41 | 35.14 | 41.55 | 35.23 | 35.92 | |||||
EBIT / Interest Expense | 34.91 | 78.26 | 33.72 | 15.87 | 14.24 | |||||
EBITDA / Interest Expense | 42.77 | 87.19 | 38.74 | 18.23 | 16.79 | |||||
(EBITDA - Capex) / Interest Expense | 38.5 | 80.37 | 32.02 | 15.31 | 14.2 | |||||
Total Debt / EBITDA | 1.17 | 0.59 | 1.17 | 0.64 | 0.9 | |||||
Net Debt / EBITDA | 0.67 | 0.24 | 0.76 | 0.38 | 0.58 | |||||
Total Debt / (EBITDA - Capex) | 1.3 | 0.64 | 1.41 | 0.76 | 1.07 | |||||
Net Debt / (EBITDA - Capex) | 0.74 | 0.26 | 0.92 | 0.45 | 0.69 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -13.44 | 19.23 | 38.98 | -0.89 | -7.3 | |||||
Gross Profit, 1 Yr. Growth % | -7.15 | 18.86 | 23.97 | 11.88 | -9.77 | |||||
EBITDA, 1 Yr. Growth % | -5.63 | 58.47 | 20.86 | 12.08 | -9.01 | |||||
EBITA, 1 Yr. Growth % | -8.39 | 69.29 | 19.81 | 12.22 | -10.41 | |||||
EBIT, 1 Yr. Growth % | -8.64 | 72.12 | 19.51 | 11.67 | -11.02 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -8.63 | 67.35 | 5.3 | 1.65 | -12.04 | |||||
Net Income, 1 Yr. Growth % | -8.63 | 67.35 | 5.3 | 1.65 | -12.04 | |||||
Normalized Net Income, 1 Yr. Growth % | -10.93 | 77.17 | 19.71 | 6.15 | -10.04 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -8.7 | 67.38 | 5.3 | 1.65 | -12.04 | |||||
Accounts Receivable, 1 Yr. Growth % | -12.05 | 37.67 | 28.2 | -16.34 | 3.84 | |||||
Inventory, 1 Yr. Growth % | -21.35 | 58.96 | 41.12 | -14.75 | 6.31 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -14.1 | 7.47 | 33 | 8.29 | 7.97 | |||||
Total Assets, 1 Yr. Growth % | -13.5 | 19.17 | 31.12 | -4.44 | 10.56 | |||||
Tangible Book Value, 1 Yr. Growth % | 92.97 | 205.23 | -43.46 | 90.63 | -19.99 | |||||
Common Equity, 1 Yr. Growth % | -6.39 | 27.56 | 18.17 | 5.88 | 9.38 | |||||
Cash From Operations, 1 Yr. Growth % | 0.64 | 1.26 | 7.77 | 35.94 | -23.52 | |||||
Capital Expenditures, 1 Yr. Growth % | -14.03 | 22.59 | 122.53 | 3.53 | -12 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -16.71 | 7.52 | -19.42 | 142.47 | -23.51 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -16.17 | 6.84 | -16.38 | 142.22 | -22.26 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 30.43 | 20 | 11.11 | 5 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -1.26 | 1.59 | 28.72 | 17.36 | -4.15 | |||||
Gross Profit, 2 Yr. CAGR % | 0.41 | 5.05 | 21.39 | 17.77 | 0.47 | |||||
EBITDA, 2 Yr. CAGR % | -2.03 | 22.29 | 25.99 | 16.56 | 0.99 | |||||
EBITA, 2 Yr. CAGR % | -3.52 | 24.54 | 28.76 | 16.14 | 0.27 | |||||
EBIT, 2 Yr. CAGR % | -4.64 | 25.4 | 29.35 | 15.72 | -0.32 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -7.48 | 23.66 | 32.75 | 3.46 | -5.44 | |||||
Net Income, 2 Yr. CAGR % | -7.48 | 23.66 | 32.75 | 3.46 | -5.44 | |||||
Normalized Net Income, 2 Yr. CAGR % | -6.85 | 25.62 | 31.15 | 12.92 | -2.28 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -7.5 | 23.62 | 32.76 | 3.46 | -5.44 | |||||
Accounts Receivable, 2 Yr. CAGR % | -4.82 | 10.04 | 32.85 | 3.56 | -6.79 | |||||
Inventory, 2 Yr. CAGR % | -11.76 | 11.81 | 49.77 | 9.68 | -4.8 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 6.35 | -3.91 | 19.56 | 20.01 | 8.13 | |||||
Total Assets, 2 Yr. CAGR % | 2.11 | 1.53 | 25 | 11.94 | 2.79 | |||||
Tangible Book Value, 2 Yr. CAGR % | -18.71 | 142.69 | 31.37 | 3.82 | 23.5 | |||||
Common Equity, 2 Yr. CAGR % | 3.1 | 9.28 | 22.78 | 11.86 | 7.62 | |||||
Cash From Operations, 2 Yr. CAGR % | 14.7 | 0.95 | 4.47 | 21.04 | 1.97 | |||||
Capital Expenditures, 2 Yr. CAGR % | 9.32 | 2.66 | 65.17 | 51.78 | -4.55 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 58.77 | -5.36 | -18.74 | 40.26 | 36.18 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 59.11 | -5.36 | -17.29 | 42.77 | 37.22 | |||||
Dividend Per Share, 2 Yr. CAGR % | 1.1 | 14.21 | 25.11 | 15.47 | 8.01 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 3.15 | 5.14 | 12.77 | 17.98 | 8.49 | |||||
Gross Profit, 3 Yr. CAGR % | 3.51 | 6.22 | 11.02 | 18.13 | 7.76 | |||||
EBITDA, 3 Yr. CAGR % | 1.26 | 15 | 14.42 | 21.29 | 7.33 | |||||
EBITA, 3 Yr. CAGR % | 0.36 | 16.37 | 14.95 | 23.13 | 6.51 | |||||
EBIT, 3 Yr. CAGR % | -0.52 | 16.1 | 15.19 | 23.3 | 6.01 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -2.65 | 12.73 | 17.21 | 21.45 | -1.99 | |||||
Net Income, 3 Yr. CAGR % | -2.65 | 12.73 | 17.21 | 21.45 | -1.99 | |||||
Normalized Net Income, 3 Yr. CAGR % | -1.6 | 15.41 | 15.28 | 22.36 | 4.68 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -2.67 | 12.72 | 17.18 | 21.46 | -1.99 | |||||
Accounts Receivable, 3 Yr. CAGR % | 7.24 | 7.64 | 15.78 | 13.87 | 3.65 | |||||
Inventory, 3 Yr. CAGR % | 7.24 | 7.37 | 20.83 | 24.12 | 8.55 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 8.89 | 6.72 | 7.08 | 15.68 | 15.86 | |||||
Total Assets, 3 Yr. CAGR % | 13.35 | 7.51 | 10.57 | 14.3 | 11.48 | |||||
Tangible Book Value, 3 Yr. CAGR % | -29.27 | 26.34 | 49.33 | 48.73 | -4.81 | |||||
Common Equity, 3 Yr. CAGR % | 9.22 | 10.68 | 12.16 | 16.87 | 11.03 | |||||
Cash From Operations, 3 Yr. CAGR % | 11.83 | 10.03 | 3.17 | 14.05 | 3.87 | |||||
Capital Expenditures, 3 Yr. CAGR % | 7.95 | 13.57 | 32.86 | 41.35 | 26.56 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 7.58 | 39.43 | -18.07 | 17.25 | 14.59 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 8.15 | 39.33 | -16.92 | 18.59 | 16.59 | |||||
Dividend Per Share, 3 Yr. CAGR % | 5.66 | 10.06 | 16.11 | 20.26 | 11.87 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 3.64 | 8.03 | 12.71 | 9.87 | 5.68 | |||||
Gross Profit, 5 Yr. CAGR % | 2.79 | 6.45 | 10.32 | 10.7 | 6.67 | |||||
EBITDA, 5 Yr. CAGR % | 1.26 | 11.4 | 10.51 | 11.36 | 8.91 | |||||
EBITA, 5 Yr. CAGR % | 0.51 | 12.13 | 10.88 | 11.68 | 8.91 | |||||
EBIT, 5 Yr. CAGR % | -0.09 | 11.86 | 10.49 | 11.26 | 8.79 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 0.23 | 11.04 | 10.21 | 8.93 | 7.56 | |||||
Net Income, 5 Yr. CAGR % | 0.23 | 11.04 | 10.21 | 8.93 | 7.56 | |||||
Normalized Net Income, 5 Yr. CAGR % | -0.71 | 11.67 | 10.38 | 9.71 | 7.98 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 0.21 | 11.02 | 10.2 | 8.92 | 7.55 | |||||
Accounts Receivable, 5 Yr. CAGR % | 10.79 | 15.25 | 16.83 | 5.99 | 6.16 | |||||
Inventory, 5 Yr. CAGR % | 9.28 | 17.21 | 22.57 | 8.29 | 9.84 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 6.56 | 6.85 | 13.04 | 11.85 | 7.5 | |||||
Total Assets, 5 Yr. CAGR % | 11.56 | 12.77 | 17.87 | 9.26 | 7.39 | |||||
Tangible Book Value, 5 Yr. CAGR % | -21.24 | -8.37 | -9.39 | 16.8 | 38.41 | |||||
Common Equity, 5 Yr. CAGR % | 7.94 | 9.04 | 14.45 | 11.15 | 10.32 | |||||
Cash From Operations, 5 Yr. CAGR % | 6.19 | 7.07 | 8.82 | 14.31 | 2.69 | |||||
Capital Expenditures, 5 Yr. CAGR % | 8.91 | 12.44 | 27.97 | 27.54 | 16.4 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 4.92 | 6.09 | -3.85 | 32.36 | 0.53 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 5.2 | 6.32 | -2.85 | 33.38 | 1.68 | |||||
Dividend Per Share, 5 Yr. CAGR % | 6.23 | 11.38 | 13.05 | 12.2 | 12.8 |
- Stock Market
- Equities
- HPOL B Stock
- Financials HEXPOL AB
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















